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Getting Real About Essential Medicines: “The 
Last Kilometer” 
LUCIE WHITE†  
I. INTRODUCTION 
International law recognizes a person’s right to essential medi-
cines as part of the individual’s overall human right to health. But what 
does it take to realize this right? What does it take to deliver life-saving 
medicines that “last kilometer,”1 from the pharmaceutical conglomer-
ates in rich and emerging nations to the people who need them, often 
with little bargaining power? At what point in the supply chain has 
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 1.  The “last kilometer” problem is often invoked in the global health context to illustrate 
the challenges of ensuring actual access to essential medicines on the ground to the people 
who need them, even those who are the hardest to reach or access. See, e.g., Hally Mahler et 
al., Covering the Last Kilometer: Using GIS to Scale-Up Voluntary Medical Male Circumci-
sion Services in Iringa and Njombe Regions, Tanzania, 3 GLOBAL HEALTH 503 (2015) (“The 
global health community frequently invokes the concept of the ‘last mile’ or, in the case of 
Tanzania, the ‘last kilometer’ to refer to achieving coverage for those clients who are the most 
difficult to reach.”); Marc Gunther, Sue Desmond-Hellmann of the Gates Foundation Wants 
an A-Plus, NONPROFIT CHRONICLES (Nov. 8, 2015), https://nonprofitchroni-
cles.com/2015/11/08/sue-desmond-hellman-of-the-gates-foundation-wants-an-a-plus (“For 
people who are interested in making a difference, the polio journey has a couple of learn-
ings . . . . One is that technical tools aren’t enough. We have the technical tools. We have the 
vaccine. On the other hand, getting that last kilometer, delivering the vaccine, getting it to 
people in difficult areas . . . is the journey.”). 
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enough been done? When the drug has been discovered? Manufac-
tured? Made affordable, or shipped to the nation or region where it is 
needed? When it has been distributed to clinics or to patients for the 
first time? Or is it when the medication is given on an ongoing basis? 
What does it actually take to realize the human right to essential med-
icines, and where should we draw the line? This essay poses this de-
ceptively simple question.   
We start with a story set in an almost middle income West African 
nation with a stably democratic government and a good national health 
care system.2 Assume that the right to essential medicines has been 
both recognized by the nation’s law and implemented, at least in the 
case of some drugs, within the nation’s borders.3 Thus, the govern-
ment’s appropriate agency has composed a list of essential medicines 
based on the World Health Organization’s (WHO) guidelines,4 deals 
with pharmaceutical producers and suppliers have been cut, and actual 
supplies of the drugs have arrived in the nation’s ports of entry. As-
sume further that the drugs in question are either free or inexpensive 
because they are off-patent, readily available, and often deeply subsi-
dized from international sources. According to a human rights analy-
sis, has the right to essential medicines with respect to this drug been 
achieved because the drug has been placed on the nation’s essential 
medicines list, shipped inside its borders, and made available to the 
 
 2.  This introductory narrative is a fictional composite that is loosely based on first-hand 
experience that I have had over several years of work in West Africa as well as extensive 
personal experience with mental health systems in well-resourced but highly unequal societies 
like the United States. Subsequent parts of the essay occasionally draw on the specific legal 
frameworks, policies, social contexts, and ground-level challenges facing Ghana in the context 
of its dual commitments to universal access to essential medicines on the one hand and the 
more comprehensive right to health on the other. I use Ghana as an exemplary nation in taking 
on these dual challenges and in making substantial progress in responding to them. I have been 
both instructed and inspired by Ghana’s global leadership in the mental health domain, in 
particular, while at the same time, I cannot help but be reminded—from my work in Ghana 
and the United States—of how long we have to go before we can fully realize these goals. 
 3.  The World Health Organization provides guidance for countries in developing and 
implementing national drug policies, highlighting “key components” of such policies like the 
selection of essential drugs, affordability, financing, supply systems, regulations, rational use, 
research, human resources development, and monitoring and evaluation. See WORLD HEALTH 
ORGANIZATION [WHO], HOW TO DEVELOP & IMPLEMENT A NATIONAL DRUG POLICY (2d ed. 
2001), http://apps.who.int/medicinedocs/pdf/s2283e/s2283e.pdf. 
 4.  The WHO Expert Committee on the Selection and Use of Essential Medicines main-
tains and updates both the WHO Model List of Essential Medicines and WHO Model List of 
Essential Medicines for Children, recommending “essential medicines” for different disease 
classes. These recommendations are meant to serve as a guide for countries institutions in 
forming their own essential medicines lists. See WHO Expert Comm. on the Selection & Use 
of Essential Meds., The Selection & Use of Essential Medicines, 994 WHO TECHNICAL REP. 
SERIES (2015). 
WHITEFINALBOOKPROOF (DO NOT DELETE) 2/16/2017  2:48 PM 
2016] GETTING REAL ABOUT ESSENTIAL MEDICINES 81 
people who need it at an affordable cost?5 
Yes and no.  As the following story will show, to evaluate whether 
peoples’ right to essential medicines has in fact been fully realized, we 
must analyze the issue from where the people who need the drug actu-
ally stand. 
II. A STORY 
Let’s consider the issue from the perspective of an eighteen-year-
old girl named “A,” an aspiring primary school teacher, who lives in 
the north of the West African nation, about thirty kilometers west of 
the nearest village with a cell phone tower and electrical power. Unlike 
the thriving coastal region, this part of the nation is highly economi-
cally deprived.  Indeed, families make ends meet by subsistence farm-
ing and remittances from family members. They suffer from many 
health challenges, including undiagnosed cancer; mobility impair-
ments from childhood polio; river blindness; respiratory problems 
linked to cooking over charcoal fires; cholera and diarrhea from waste-
polluted water; malaria; cardiovascular disease and diabetes linked to 
development-driven lifestyle changes; chronic exhaustion linked to 
farming in drought-parched soil; chronic severe depression; and other 
debilitating mental health conditions. 
Due to the remoteness of the village, A had walked fifteen kilo-
meters a day for a decade to complete secondary school and planned 
to travel south to seek work as a porter in the capital city’s sprawling 
central market. However, her plans are interrupted, because over sev-
eral weeks A becomes more and more agitated. She has racing thoughts 
and her words start to rush together. She loses sleep. Eventually, her 
behavior makes no sense at all, and she begins to threaten and strike 
out at family members who try to calm her down. 
Unsure of what to do, A’s family takes her to a local “prayer 
camp” where the pastors use harsh herbs and violent rituals to control 
her.6 Her family eventually brings her home and, without other re-
course, secures her with a log in a shed behind their compound, as other 
 
 5.  United Nations [U.N.] Econ. & Soc. Council, Comm. on Econ., Soc. & Cultural 
Rights, General Comment No. 14: The Right to the Highest Attainable Standard of Health 
(Article 12 of the International Covenant on Economic, Social, and Cultural Rights), ¶ 12, 
U.N. Doc. E/C.12/2000/4 (Aug. 11, 2000) [hereinafter General Comment No. 14]. 
 6.  See generally HUMAN RIGHTS WATCH, LIKE A DEATH SENTENCE 30–36 (2012), 
https://www.hrw.org/sites/default/files/reports/ghana1012webwcover.pdf. 
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families have done to manage the same situation. Troubled by this “op-
tion,” they talk with many people in the area and decide to risk a jour-
ney to the government clinic in the district capital—a village just over 
fifty kilometers away where doctors are said to have “real drugs” that 
can make their daughter quiet. They borrow a motor bike and, through 
great effort, confine her in order to make the journey. So what happens 
when they get there? There are several possibilities: 
The clinic could be closed due to a shortage of staff. 
The clinic could be open, but, with staff who lack basic mental 
health training. 
Or the clinic could have a visiting nurse on staff with some basic 
mental health training who visits the clinic once a week. 
If A’s family chooses to wait, then the nurse might arrive. She 
might then tell them to go back to the prayer camp and be patient, or 
to see a traditional healer in her village. She could also say that A’s 
condition is “manic depression” and direct them to the psychiatric hos-
pital in the capital city on the coast, some fourteen hours to the south 
by bus. There, A might become an “inmate,”7 who at times is confined 
in a large open space with thirty others who have similar conditions.  
A might occasionally be cared for by dedicated nurses, but the hard-
pressed psychiatrists who work in the nation’s public mental health 
system, would be far too busy to devote much time to her care.8 
Alternatively, instead of sending the family to the city, the nurse 
who occasionally visits the community clinic might agree to help them. 
She might start by asking for the family’s national health insurance 
card to pay for the treatment A will receive. The family is not enrolled 
 
 7.  In Ghana, mental health patients are commonly referred to as “inmates” despite the 
country putting forth reforms meant to address such stigma. Even though the law itself has 
changed, it takes public education—and time—for such changes to become common parlance 
across the population, especially in dispersed areas of the country. See, e.g., Masahudu Ankiilu 
Kunateh, Inmates of Pantang Hospital Get Free NHIS Cards, GHANAIAN CHRON. (Jan. 24, 
2013), http://thechronicle.com.gh/inmates-of-pantang-hospital-get-free-nhis-cards; Mental 
Health Inmates Deserve Dignity - Activists, GHANA NEWS AGENCY (Oct. 12, 2015), 
http://www.ghananewsagency.org/health/mental-health-inmates-deserve-dignity-activists-
95606. See generally, IRIN, Ghana’s New Mental Health Bill Aims to Address Stigma, 
GUARDIAN (Aug. 29, 2011), http://www.theguardian.com/global-develop-
ment/2011/aug/29/ghana-new-mental-health-bill. 
 8.  For example, Ghana was reported to be spending only 1.4% of its total health ex-
penditures on mental health in 2011 and that low level of services was found to be concentrated 
in the urban areas, leaving virtually no resources in more rural areas. Mark Roberts et al., An 
Overview of Ghana’s Mental Health System: Results from an Assessment Using the World 
Health Organization’s Assessment Instrument for Mental Health Systems (WHO-AIMS), INT’L 
J. MENTAL HEALTH SYS. (May 4, 2014), http://www.ijmhs.com/content/8/1/16. 
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in the health insurance scheme, however, because they cannot afford 
the annual premium.  Yet the nurse does not know that she should not 
have asked for the card at all since mental health services are supposed 
to be free to everyone, whether or not a person is enrolled in the na-
tional health insurance scheme.9 
Among the essential medicines to which A may be legally entitled 
to10 for manic depression (or bipolar mania, as the doctors call it) is 
lithium, a naturally occurring element that is inexpensive for the gov-
ernment to obtain and is readily available—though not always used—
in the capital city to the south. Yet even so, in the far northern govern-
ment clinics where A is likely to be taken, the drug is often not there. 
Or if the clinic has the drug available, the nurse might not know 
that it will help A. Or if she does know, she may not remember the 
dosage she should give to avoid a toxic overdose. Alternatively, if the 
nurse does know how much of the drug to give A, she might not be 
able to let her patient stay in the clinic overnight and thus must send 
her away with a bottle of pills to take when she gets home. But in either 
case, neither the clinic nor A’s family will have the equipment, or the 
technical training, to monitor her blood levels on a regular basis so as 
to protect against toxicity in the future. Thus, without access to follow-
up testing, A might become very sick. Or she might die.   
But before this scenario even happens, it is more likely that her 
family will stop giving her the drug. They might then take her back to 
the clinic to have the nurse sort things out, which, without equipment 
and know how, she won’t be able to do. They might take her back to a 
prayer camp. Or they might secure her in the shed once more, releasing 
her under their guard to do house chores when they can. 
 
 9.  For example, although people are entitled to free mental health care under the terms 
of Ghana’s Mental Health Act of 2012 § 88 (Act No. 846/2012), the National Health Insurance 
Act further provides that “a person with mental disorder” is exempted from paying to enroll 
in the National Health Insurance Scheme (NHIS) and is entitled to the NHIS’s health benefits 
as a member. National Health Insurance Act § 29(c) (Act No. 852/2012) (Ghana). 
 10.  For example, people enrolled in Ghana’s National Health Insurance Scheme are en-
titled to certain essential psychiatric medications under the terms of that program. See National 
Health Insurance Act § 33(1) (declaring that the National Health Insurance Scheme Medicine 
List shall be “derived from the Essential Medicines List approved by the Minister,” which in 
turn is based off the WHO’s Model List of Essential Medicines); Benefits Package, NAT’L 
HEALTH INS. SCHEME (Ghana), http://www.nhis.gov.gh/benefits.aspx (last visited Apr. 12, 
2016) (listing NHIS’s benefits and excluding medicines not on the NHIS Medicines List). 
Compare NHIS Medicines List, NAT’L HEALTH INS. SCHEME (Ghana), 
http://www.nhis.gov.gh/medlist.aspx (last visit Apr. 12, 2016) (listing medicines covered by 
the NHIS), with MINISTRY OF HEALTH: GHANA NATIONAL DRUGS PROGRAMME, GHANA 
ESSENTIAL MEDICINES LIST (6th ed. 2010). 
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International human rights groups or investigative journalists 
might then come to A’s family home, or the homes of others like them, 
to expose A’s plight as a human rights violation typified by her failure 
to receive an essential medicine that she should have been entitled to. 
Those groups might note that, while A was thus deprived of her basic 
rights, the drug that she needed was in plentiful supply. For it is easier 
for such commentators, or accusers, to portray the story’s end as a hu-
man rights wrong than to map out the systemic failures that the chain 
of “perpetrators” confronts along the way.11 
III. HUMAN RIGHTS VIOLATIONS? 
The story of A is a story of multiple failings, not in the perfor-
mance of individuals or corporate entities, but in the institutions and 
systems that failed to deliver the medicine that “last kilometer” to the 
people who need them. To some degree these failings can be attributed 
to a shortage of money and the human competencies required to per-
form needed mental health roles.12 Yet it is not just a question of 
money. It is also a question of how the money and people that can 
reasonably be made available can be woven together into synergistic 
systems of care. 
A. Promoting the Right to Essential Medicines: A Systems 
Perspective 
The point of this paper is that if we are serious about realizing the 
right to essential medicines, we must evaluate that right to essential 
 
 11.  This paragraph, as well as the following, suggest not just the need for systemic anal-
ysis in order to identify the causes of, and point toward potential remedies for, ostensible “hu-
man rights violations.” The paragraph also suggests that conventional economic and social 
rights analyses, when it fails to do a systemic analysis, ends up blaming not so much the victim, 
but those actors in a complex bureaucracy, like the nurses, psychiatrists, or family, in A’s 
situation, who are doing their very best to respond to her needs with critically limited resources 
which are themselves only forthcoming within the context of inadequate delivery systems. 
Such a scenario can be deemed as an example of “structural violence,” which has been defined 
as the following: 
The term “structural violence” is one way of describing social arrangements that put individ-
uals and populations in harm’s way. The arrangements are structural because they are embed-
ded in the political and economic organization of our social world; they are violent because 
they cause injury to people (typically, not those responsible for perpetuating such inequalities). 
With few exceptions, clinicians are not trained to understand such social forces, nor are we 
trained to alter them. Yet it has long been clear that many medical and public health interven-
tions will fail if we are unable to understand the social determinants of disease. 
Paul Farmer et al., Structural Violence and Clinical Medicine, 3 PLOS MED. 1686, 1686–87 
(2006). 
 12.  WHO, MENTAL HEALTH LEGISLATION & HUMAN RIGHTS 6 (2003), 
http://www.who.int/mental_health/resources/en/Legislation.pdf. 
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medicines from rights holders’ perspectives.  We must not just count 
the sale price of pills on the shelves. Rather, we must do the much 
harder work of keeping an eye on the pills as we contrast the journeys 
of rights holders through existing systems of care against optimal ones. 
Did those people end up getting the medicines they were entitled to on 
an ongoing basis? If not, what didn’t they get? And where did the sys-
tem break down? It is at these points of system breakdown, in situ, 
where the human rights violations lie. 
Viewing human rights realization from such a systemic perspec-
tive is crucial for many reasons. Among the most important is that a 
“smart” change in system design can save a lot of money in contexts 
where money is short13; conversely, a very large increase in budget will 
have little impact without the system’s capacity to “absorb” those 
funds in productive ways.14 
B. Why Start with A?: “From Margin to Center”15 
Why start with A’s case in an essay arguing that the right to es-
sential medicines must be understood in systemic terms?  Isn’t her 
chronic mental illness at the margins of the whole concept of essential 
medicines? For instance, shouldn’t we be starting our analysis with 
malaria or Ebola, i.e., those infectious diseases that put us at risk of 
widespread epidemics and for which we need a pharmaceutical cure?   
Indeed, what do we gain by centering our analysis of essential 
 
 13.  See, e.g., Bella English, In Rwanda, Visionary Doctor Is Moving Mountains Again, 
BOSTON.COM (Apr. 13, 2008), http://archive.boston.com/news/world/arti-
cles/2008/04/13/in_rwanda_visionary_doctor_is_moving_mountains_again (discussing Paul 
Farmer’s work in Rwanda, where a primary care system that used community-based paramed-
ics in a thoughtful way both greatly improved quality and saved valuable resources at the same 
time). 
 14.  In the context of global health aid, Jeffrey Sachs argues against the notion that a 
health sector’s insufficient “absorptive capacity” with respect to lacking infrastructure and 
capital can render excess aid futile. Rather, keeping those system constraints in mind, such aid 
can be used to address those constraints or channeled in alternative ways to further the provi-
sion of health care. JEFFREY SACHS, THE END OF POVERTY 274 (2005). 
 15.  BELL HOOKS, FEMINIST THEORY: FROM MARGIN TO CENTER (1984). We have used 
A’s case as a lens similar to the lens adopted by noted radical feminist Bell Hooks (also known 
as Gloria Watkins), using her experiences living in black America, in order to assess central, 
systemic issues in the eyes of one who experiences the negative effects of those issues at the 
outskirts of the system. As Hooks wrote in the preface to her book Feminist Theory: 
To be in the margin is to be part of the whole but outside the main body . . . . Living as we 
did—on the edge—we developed a particular way of seeing reality. We looked from both the 
outside in and the inside out. We focused our attention on the center as well as the margin. We 
understood both. This mode of seeing reminded us of the existence of a whole universe, a main 
body made up of both margin and center. 
Id. at ix. 
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medicines on A’s situation?  The answer is simply this: expanding the 
concept of essential medicines to respond to A’s treatment needs will 
help us expand our understanding of what kinds of “medicines,” in its 
holistic meaning, are required for all health conditions, even those that 
are wrongly perceived to respond to one-time chemical treatment 
alone. 
So what are the features of mental health conditions that challenge 
our limited conception of “medicine” for all health conditions?16 Four 
of these features stand out. First, since its origins, the policy of listing 
essential medicines has focused on infectious diseases generally oc-
curring in previously colonized regions. Such diseases were believed 
to cause widespread epidemics if the infected person was not either 
isolated from others or cured through chemical intervention.  Mental 
health conditions, in contrast, often benefit from drugs, but only in the 
context of ongoing practices of family and community-embedded care. 
Second, though our core concept of essential medicines has finally be-
gun to expand to include drugs for noncommunicable diseases (NCDs) 
like diabetes, arteriosclerosis, and cancer, those diseases are too often 
considered treatable by “miracle” drugs like insulin, rather than 
through drugs in the context of comprehensive care. We have seen that 
mental health conditions, without exception, require treatment in the 
context of networks of ongoing care. Third, unlike both infectious dis-
eases and NCDs, mental health conditions are not yet perceived to be 
somatic. Yet since they are, in fact, both somatic and more, they chal-
lenge the rigid division between that part of the person that can be 
treated with “medicines” and that part which is outside their scope. 
Fourth, mental health conditions are highly stigmatized across many 
cultures. Indeed, many mental health conditions are widely believed to 
be afflictions of character or spirit rather than body. They thus impose 
stigma on caretakers, taxing their courage, as well as patience, in pro-
found ways. Though this feature of mental health conditions may be 
viewed as unique, this shadow of stigma has and continues to affect 
the experience and concept of illness itself, and the caretakers who re-
spond to afflicted people’s needs. 
In conclusion, let us imagine bringing these four features of men-
tal health conditions from the “margin to center” in our analysis of the 
“medicine” required to treat all health conditions, even those which at 
first glance appear to fit most tightly into the predominant paradigm. 
Consider Ebola. A vaccine and effective antiviral medications will 
 
 16.  The following stereotypes are based on my own practical experience with mental 
health advocacy and broad knowledge of both stereotypes and realities surrounding it. 
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help, but the disease afflicts more than the body of the infected person 
alone. It also affects the wellbeing and resilience of the patient and her 
family and community in comprehensive ways. It cannot be either con-
tained or effectively treated unless there are longer term drug treat-
ments; community-based preventative and responsive practices; edu-
cation and awareness to combat stigma; and both patience and courage 
among the many affected people. 
C. The Right to Drugs / The Right to Care: A Call for Pragmatic 
Action 
Thus, I take the hard case of A’s bipolar condition to challenge 
and contribute to the reframing of the right to essential medicines from 
rights holders’ perspectives in the following way. Let us start by re-
framing human rights and “economic and social rights,” like the right 
to essential medicines in particular, as something other than lists of 
discrete pharmaceutical products. Let us understand that right not as a 
tangible thing, but as a call to action. Let us understand that right not 
just as a call to action but as a call for pragmatic action—a call for 
specific, feasible steps that people can take together in various ways. 
Let us understand pragmatic action as action that addresses the treat-
ment challenge from the bottom up and top down, so as to connect 
people with what they need to maintain wellbeing, even while sick, not 
through drugs alone, but through drugs within systems of care.   
I will contribute to this reframing in the following way. First, I 
will show how the concept of essential medicines since its origins has 
been constrained within a formalistic frame. Second, I will show how 
the dominant frame for understanding human rights has been similarly 
formalistic. Thus, rather than nudging our understanding of health 
rights toward pragmatic action, the convergence of human rights doc-
trine and essential medicines policy has undermined that goal. Third, I 
will show how the movement for HIV/AIDS treatment, specifically in 
the context of antiretroviral (ARV) drugs, finally reframed the right to 
essential medicines from a formalistic conception into a call for social 
movement and pragmatic action for change. Next, I will discuss the 
limits and potential of the HIV treatment access movement from the 
perspective of both HIV-affected individuals and people like A af-
fected by other health conditions. Finally, I will show how a public 
health movement that embeds within it the right to essential medicines 
can transform the demand for “access to essential medicines” into a 
call—and a movement—for holistic systems of care.     
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1. On Essential Medicines 
The concept of essential medicines has, from its origins, been 
constrained within a formalistic frame. It had its modern origins in the 
aftermath of World War I, when the WHO was founded.17 Since then, 
the WHO has developed the concept in a more and more detailed way. 
This effort reached a turning point in 1977, when the WHO first issued 
an annual list of recommended essential medicines, along with the rec-
ommendation that individual nations draw from this list to create their 
own lists of essential medicines to respond to their own contexts.18 
Each nation was then to use its list to inform a range of specific health 
policy decisions, from determining which drugs would be available 
free of charge in public hospitals and clinics, to which drugs would be 
reimbursed by public insurance and subsidy programs, to similar poli-
cies. Over 150 nations have now opted into this essential medicines 
scheme.19 
The WHO compiles its official essential medicines list on the ba-
sis of a cost/benefit calculus that takes account of factors that include 
cost; comparative effectiveness; safety; ease of dispensing and use; 
and the like.20 The list is revised every two years as new drugs reach 
the market, older drugs become less expensive, the disease burden 
shifts, and the calculus’s bottom line therefore changes.21 The WHO’s 
most recent list was issued in April 2015.22 Its listed drugs cover the 
full range of common medical conditions for both infectious and non-
communicable diseases and major mental health conditions. It would 
be a remarkable global health accomplishment for all of the drugs on 
the WHO list to be actually available and effectively administered on 
 
 17.  John Charles, Origins, History, and Achievements of the World Health Organization, 
2 BRIT. MED. J. 293, 294 (1968). 
 18.  Richard Laing et al., 25 Years of the WHO Essential Medicines Lists: Progress and 
Challenges, 361 LANCET 1723, 1723 (2003). WHO’s conception of essential medicines has 
evolved over time, initially defined as those medicines that were “of utmost importance, basic, 
indispensable and necessary for the health and needs of the population.” Id. Today, essential 
medicines are recognized as “those that satisfy the priority health care needs of the population 
and “are selected with due regard to public health relevance, evidence on efficacy and safety, 
and comparative cost-effectiveness.” Essential Medicines, WHO, http://www.who.int/top-
ics/essential_medicines/en/ (last visited Apr. 29, 2016). 
 19.  Laing, supra note 18. 
 20.  WHO, WHO Medicines Strategy: Revised Procedure for Updating WHO’s Model 
List of Essential Drugs, annex, WHO Doc. EB109/8 (Dec. 7, 2001), http://apps.who.int/med-
icinedocs/documents/s22165en/s22165en.pdf. 
 21.  See, e.g., WHO Moves to Improve Access to Lifesaving Medicines for Hepatitis C, 
Drug-Resistant TB and Cancers, WHO (May 8, 2015), http://www.who.int/mediacen-
tre/news/releases/2015/new-essential-medicines-list/en. 
 22.  WHO Expert Comm. on the Selection & Use of Essential Meds., supra note 4, annex 
I. 
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a regular basis to all people in need of them, in rural as well as urban 
areas, low income as well as affluent regions, powerful as well as less 
powerful enclaves, all over the globe. Needless to say, this is not the 
case, nor do WHO’s health policy strategists expect that such a high-
level intervention, taken alone, ought to be sufficient to produce that 
result.23 
2. On Human Rights 
This history might also be traced back to the World War I era, but 
its defining moment came at the close of World War II, when, under 
the guidance of Eleanor Roosevelt and others, the Universal Declara-
tion of Human Rights24 was drafted.25 In this defining moment, the idea 
of a right to health was not treated at length. Nonetheless, the document 
created the foundational text—the constitutional framework—on 
which the International Covenant of Economic, Social, and Cultural 
Rights (ICESCR) subsequently codified a formal right to health in 
greater detail in its Article 12.26 The Covenant placed the legal burden 
on nation states to take steps to “progressively realize” the right to 
health to the degree that they are able to under the circumstances.27 
The ICESCR was itself explicated in great detail in the highly 
 
 23.  See generally WHO, supra note 3. As the WHO has recognized: 
These problems [of lack of access to essential drugs, poor quality, and irrational 
use] have persisted despite all the work done to improve access to essential drugs, 
to ensure drug quality and to promote rational drug use. The reasons are complex 
and go beyond simple financial constraints. To understand them it is necessary 
to look at the characteristics of the drug market, and to study the attitudes and 
behavior of governments, prescribers, dispensers, consumers and the drug indus-
try. Health sector development, economic reform, structural adjustment policies, 
trends towards liberalization, and new global trade agreements all have a poten-
tial impact on the pharmaceutical situation in many countries. They may also 
affect the ultimate goal of achieving equity in health. 
Id. at 4. 
 24.  G.A. Res. 217 (III) A (Dec. 10, 1948). 
 25.  History of the Document, U.N., http://www.un.org/en/sections/universal-declara-
tion/history-document/index.html (last visited Apr. 13, 2016). 
 26.  G.A. Res. 2200A (XXI), annex, at 51 (Dec. 16, 1966). 
 27.  Id. at 49 (“Each State Party to the present Covenant undertakes to take steps, individ-
ually and through international assistance and co-operation, especially economic and tech-
nical, to the maximum of its available resources, with a view to achieving progressively the 
full realization of the rights recognized in the present Covenant by all appropriate means, in-
cluding particularly the adoption of legislative measures.” [emphasis added]); Hans V. 
Hogerzeil & Zafar Mirza, THE WORLD MEDICINES SITUATION 2011: ACCESS TO ESSENTIAL 
MEDICINES AS PART OF THE RIGHT TO HEALTH § 1.1.1–.3, WHO (2011), 
http://apps.who.int/medicinedocs/documents/s18772en/s18772en.pdf (summarizing the bases 
for the legal enforceability of the right to health in the ICESCR and the right to essential med-
icines that stem from that). 
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significant General Comment No. 14: The Right to the Highest Attain-
able Standard of Health (Art. 12) (Comment No. 14).28 This document 
makes clear that accessible, affordable, and high quality medicines re-
quired for persons to achieve the highest attainable standard of health, 
including essential medicines, be made available to all according to the 
Comment No. 14’s and ICESCR’s terms.29 Thus, the promulgation in 
2000 of Comment No. 14 marks a convergence of the right to health 
and essential medicines domains. Embedding the essential medicines 
policy into a broader right to health movement might now seem obvi-
ous. Yet at the time that the right to health was codified, it was not 
understood to intersect directly with the WHO’s listing of essential 
medicines. Nor was an intersection between the two domains a focus 
of advocates’ attention. Indeed, as essential medicines has gradually 
become a key health right for advocates to fight for, as well as a com-
plex inventory for experts to compose, scholars and activists alike have 
thought hard about the value of this linkage. 
Since the promulgation of Comment No. 14, the challenge of “im-
plementation” has too often been deferred.30 When it hasn’t, the most 
common method for incentivizing implementation has been using 
checklists of “indicators” that can be feasibly assessed on a national or 
international scale.31 Thus, research might assess how many of a sam-
ple of a nation’s essential medicines it has on hand, and the cost to the 
government of each. Although one might say that this sort of monitor-
ing is better than nothing, it bears noting that the focus of this moni-
toring of implementation is not from the rights holders’ perspectives, 
but from the vantage point of the nation state and international entities 
that produce and control the supply. Another illustration of this supply-
side bias in implementation advocacy is the almost exclusive focus 
among essential medicine advocates, particularly lawyers, on features 
of international intellectual property regimes—notably the require-
ments in international trade agreements for the transnational enforce-
ment of pharmaceutical patents—that have kept the cost of many drugs 
 
 28.  General Comment No. 14, supra note 5. 
 29.  Id. ¶¶ 4, 12(a). 
 30.  This gap is now widely recognized and a major focus of academic and pragmatic 
attention. See generally KATHARINE G. YOUNG, CONSTITUTING ECONOMIC AND SOCIAL RIGHTS 
(2012) (elaborating why it is so difficult for courts to adjudicate economic and social rights 
claims in ways that succeed in “getting the food on the table” and how creative constitutional 
courts, such as those in South Africa, India, and Colombia, have crafted different kinds of 
remedies that have overcome this challenge). 
 31.  See, e.g., WHO, USING INDICATORS TO MEASURE COUNTRY PHARMACEUTICAL 
SITUATIONS: FACT BOOK ON WHO LEVEL I AND LEVEL II MONITORING INDICATORS 1–2 (2006), 
http://www.who.int/medicines/publications/WHOTCM2006.2A.pdf. 
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on essential medicines lists exorbitantly high.32 
Although it goes without saying that this work is very important, 
it must be noted it crowds out other kinds of scholarly and advocacy 
work. First, this heavy focus on intellectual property issues shifts at-
tention away from other important domains where human rights issues 
can arise, such as the drugs that are excluded—or included—on a na-
tion’s list, and the law, policy, and politics through which the WHO 
and national lists are composed. Second, this emphasis on intellectual 
property issues can narrow the framing of the social movement for es-
sential medicines away from “the last kilometer,” i.e., the daunting is-
sues of law and human rights that must be addressed to get essential 
drugs—even those that are on all the lists, not covered by patent pro-
tections, and already in a nation’s port city—into rights holders’ hands. 
Although launching a social movement for essential medicines 
that is framed by human rights might seem like an unequivocal plus,33 
when the dominant, formalistic understanding of human rights guides 
the building of the movement, this turn to human rights in the essential 
medicines context has a few downsides. One cluster of costs has to do 
with the tactical limits that a human rights framework can impose on 
an essential medicines movement. For instance, a human rights frame-
work can—but need not—preclude other normative framings, like 
public health or moral duty. It can narrow the attention of lawyers and 
other advocates to a limited and sometimes highly technical range of 
values, laws, and strategies.34 This framework can also work, per-
versely, to excuse a failure to get drugs to those who need them: for, 
some human right advocates might argue, so long as the nation has 
complied with its duty to endorse the sacred “list” and procure the 
drugs, then the right has been fulfilled. Furthermore, a human rights 
framework, in any context, including essential medicines, can demo-
bilize and ramp down what might be a powerful social movement by 
channeling people’s energy into writing reports, appearing before of-
ficial commissions, filing lawsuits, and the like, rather than more ro-
bust forms of protest. 
 
 32.  See, e.g., Brook K. Baker, Patents, Pricing, and Access to Essential Medicines in 
Developing Countries, 11 VIRTUAL MENTOR 527, 528 (2009). 
 33.  Fran Quigley, The Trans-Pacific Partnership and Access to Medicines, HEALTH & 
HUM. RTS. J. (June 18, 2015), http://www.hhrjournal.org/2015/06/the-trans-pacific-partner-
ship-and-access-to-medicines. 
 34.  See generally DAVID KENNEDY, The International Human Rights Movement: Part of 
the Problem?, in THE DARK SIDES OF VIRTUE: REASSESSING INTERNATIONAL 
HUMANITARIANISM 3–35 (2004). 
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The second set of costs of a human rights framework for an es-
sential medicines movement has to do with the stylized roles within 
which the framework confines the actors who are involved. One com-
mentator has described these roles as the savages, victims, and sav-
iors.35 In this schema, the “victims,” those who need essential medi-
cines, are configured as sickly, weak, passive people who are incapable 
of feeling anger, not to mention channeling that anger into concerted 
political action. They are thus deemed unable to analyze challenges 
strategically; identifying overlapping interests, including those that 
they share with adversaries; mapping the actors’ powers and vulnera-
bilities; creating politically savvy relationships, linkages, and coali-
tions; and using human rights rhetoric and strategies deliberately, so as 
to make use of their power.36 This formidable array of capacities is 
suppressed rather than enhanced by the “victim script” in which human 
rights discourse locks them.37 
The savages-victims-saviors schema also traps the “saviors,” or 
the coalitions of doctors, lawyers, and academics, for instance, into a 
paternalistic, humanitarian stereotype, no matter what their actual in-
tentions might be.38 This humanitarian script has been trenchantly 
traced to images of colonial settings, endemic with killer diseases, 
where soldiers worked hand-in-hand with doctors to save the native 
peoples to work in the mines.39 
Finally, the savage-victim-savior schema blocks the capacity and 
motivation of all in the triad to analyze the complex structural and in-
stitutional architecture of the pharmaceutical industry and other ac-
tors—from global to local—which are part of the reason that the drugs 
are not there. This “savage” script that human rights framing40 can im-
ply does little, in the end, to generate broad and rich ideas. For as nox-
ious as a system that uses money to entice the innovation of drugs for 
elites while poor people die, even this space offers sites for reform. For 
instance, incentives for drug innovation need not come exclusively 
from the rights holders’ own market power. It might come from human 
 
 35.  Makau Mutua, Savages, Victims, and Saviors: The Metaphor of Human Rights, 42 
HARV. INT’L L.J. 201 (2001). 
 36.  See generally Jeremy Perelman & Lucie White, Stones of Hope: Experience and The-
ory in African Economic and Social Rights Activism, in STONES OF HOPE: HOW AFRICAN 
ACTIVISTS RECLAIM HUMAN RIGHTS TO CHALLENGE GLOBAL POVERTY 149–71 (Lucie White 
& Jeremy Perelman eds., 2011). 
 37.  See generally Mutua, supra note 35, at 203–204, 228–233. 
 38.  See generally id. at 204, 233–242. 
 39.  Jeremy Greene et al., Colonial Medicine and Its Legacies, in REIMAGINING GLOBAL 
HEALTH 38 (Paul Farmer et al. eds., 2013). 
 40.  See generally Mutua, supra note 35, at 202–203, 219–227. 
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rights strategists’ shaming; competition from public suppliers; philan-
thropic grants; global funds; negotiated G8 contributions; consumer 
and shareholder pressure; or an upsurge of direct social movement for 
change.41 As easy, and satisfying, as it feels to just “blame big pharma,” 
the slogan does not always lead to creative political action. 
A further problem arises when the concept of essential medicines 
is changed into a human rights movement because of a foundational 
tension embedded in the human rights concept itself. This is the tension 
between first generation “negative” rights, on the one hand, and the 
much more problematic second generation “positive” rights on the 
other.42 For example, it might be considered a clear first generation hu-
man rights violation for a nation to discriminate against women or 
other vulnerable groups in the distribution of a limited supply of es-
sential medicines.43 Or it might be considered a human rights violation 
for the government to obstruct the delivery of essential medicines to 
areas with large communities of ethnic or religious minorities.44 Or it 
might be considered a violation for the government to withhold an es-
sential medicine from an imprisoned journalist to inflict extreme 
pain—or torture—in addition to imprisonment for her opposition of 
 
 41.  See, e.g., William Forbath, Cultural Transformation, Deep Institutional Reform, and 
ESR Practice: South Africa’s Treatment Action Campaign, in STONES OF HOPE: HOW AFRICAN 
ACTIVISTS RECLAIM HUMAN RIGHTS TO CHALLENGE GLOBAL POVERTY 51–90 (Lucie White & 
Jeremy Perelman eds., 2011) (describing the movement in South Africa to require the govern-
ment to provide free ARVs to pregnant women in order to block HIV transmission to their 
newborns). 
 42.  Negative rights are those rights also considered to be civil liberties such as the free-
dom from torture, freedom of speech, freedom of the press, freedom of religion, freedom to 
assemble, and the like. These are called “negative” because they are believed to require the 
state to refrain from taking action that harms citizens or limits their fundamental liberties, 
while positive rights are the “economic and social rights” that are believed to require the state 
to act affirmatively, generally by spending money, in order to provide people the goods re-
quired for their survival, well-being, and thriving as human beings. See INTERNATIONAL 
HUMAN RIGHTS IN CONTEXT: LAW, POLITICS, MORALS 186 (Henry Steiner et al. eds., 3d ed. 
2007). 
 43.  See, e.g., Ellen Barry & Celia W. Dugger, India to Change Its Decades-Old Reliance 
on Female Sterilization, N.Y. TIMES (Feb. 20, 2016), http://www.ny-
times.com/2016/02/21/world/asia/india-to-change-its-decades-old-reliance-on-female-sterili-
zation.html (discussing recent efforts in India to make additional forms of birth control publi-
cally available for women, a shift from its historical reliance on state-sponsored sterilization 
through tubal ligation). 
 44.  See, e.g., Stephanie Nebehay et al., U.N. Fears for Hundreds of Thousands if Syria 
Troops Encircle Aleppo, REUTERS (Feb. 9, 2016), http://www.reuters.com/article/us-mideast-
crisis-syria-un-idUSKCN0VI0T8 (covering the cutting off of humanitarian aid to citizens by 
Syrian government-led troops encircling the rebel-held city of Aleppo); Jane Perlez, Death 
Stalks Muslims as Myanmar Cuts Off Aid, N.Y. TIMES (May 2, 2014), http://www.ny-
times.com/2014/05/03/world/asia/death-stalks-muslims-as-myanmar-cuts-off-aid.html (de-
tailing the cutting off of humanitarian aid and medical care by the Buddhist-led Myanmar 
government as part of a larger crackdown against the country’s Ronhingya Muslim minority). 
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the government.45 In all of these examples, the state uses its control 
over the essential medicines supply to violate one of a person’s clearly 
established “first generation” human rights. Such exploitation of the 
essential medicines framework to make it a vehicle for violating the 
most fundamental human rights of citizens is clearly an outrage, if not 
also, in some cases at least, an actionable crime. 
Yet it is much more difficult for human rights discourse to be de-
ployed to target the background economic and social conditions—
summed up in poverty—that obstruct the ground-level realization of 
the “human right” to getting high quality essential medicines in the 
context of effective essential care. For indeed, efforts of advocates to 
“stretch” human rights discourse to help deliver discrete commodities 
like housing or education have been very challenging.46 Further efforts 
to deploy human rights tools to secure complex systems of care are 
unquestionably on the cutting edge of human rights advocacy.47 But 
little progress on this front has yet been made. 
3. On HIV, MSF, and Global Poverty 
Public awareness of essential medicines increased in the 1980s 
and 1990s in the context of the AIDS crisis. Social movement arose, 
particularly in South Africa and the United States, as ARVs were de-
veloped but made unavailable to HIV-positive low income people, par-
ticularly in sub-Saharan Africa.48 Eventually, after intensive organiz-
ing by South Africa’s Treatment Action Campaign (TAC), the South 
African Constitutional Court issued a landmark decision, Minister of 
Health v. TAC,49 which required the South African government to 
make Nevirapine, an ARV, available to HIV-infected pregnant women 
 
 45.  See, e.g., China’s Ailing Prisoners, WALL ST. J. (June 29, 2015), 
http://www.wsj.com/articles/chinas-ailing-prisoners-1435595053 (reviewing the denial of 
medical treatment to reporter Gao Yu and other Chinese political prisoners by their govern-
ment). 
 46.  See, e.g., Government of the Republic of South Africa v. Grootboom 2001 (1) SA 46 
(CC) (demonstrating the difficulties of the South African Constitutional Court in delivering 
housing to citizens claiming fundamental rights to housing even though both the Constitution 
and the Court itself recognized their formal entitlement to that right).   
 47.  See, for instance, the efforts of the Colombian Constitutional Court to use its remedial 
powers in creative ways to compel the government to reform the entire institutional structure 
of the nation’s health system. See Helena Alviar García, Distribution of Resources Led By 
Courts: A Few Words of Caution, in SOCIAL AND ECONOMIC RIGHTS IN THEORY AND PRACTICE: 
CRITICAL INQUIRIES 67–81 (Helena Alviar García, Karl Klare, & Lucy A. Williams, eds., 
2015). See generally YOUNG, supra note 30. 
 48.  Mark Heywood, South Africa’s Treatment Action Campaign: Combing Law and So-
cial Mobilization to Realize the Right to Health, 1 J. HUM. RTS. PRAC. 14, 17–19 (2009). 
 49.  Minister of Health v. Treatment Action Campaign (2002) (5) SA 721 (CC). 
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to prevent the infection of their newborn children.50 Energized by this 
victory, this social movement expanded to address killer infectious dis-
eases in low income nations more broadly. Social movement cam-
paigns promoting drug treatment, universal vaccination, vaccine de-
velopment, and disease eradication for the major infectious disease 
drugs emerged across the globe.51 These campaigns helped to trans-
form WHO’s essential medicines policy into a social movement that, 
for all of their inherent limits, would nonetheless soon become framed 
in human rights terms. Because of the cost of patented ARV drugs in 
South Africa and elsewhere, the intellectual property questions became 
a major, and needed, focus of both legal strategy and social movement 
action.   
A turning point in this HIV-prompted social movement for essen-
tial medicines came in 1999, when Médecins Sans Frontières (MSF), 
or Doctors without Borders, earned a Nobel Prize and then decided to 
use the funds it was awarded to launch its own essential medicines 
movement.52 In the early 2000s, WHO began to issue its own guides to 
essential medicines advocacy.53 Since then scholars like Thomas 
Pogge54 and Jeffrey Sachs55 and philanthropists like Bill and Melinda 
 
 50.  Id. ¶ 135. 
 51.  See, e.g., Involving Everyone: Social Mobilization Is Key in an Ebola Outbreak Re-
sponse in Guinea, WHO (May 2014), http://www.who.int/features/2014/social-mobilisa-
tion/en (describing direct community outreach efforts to educate Guineans affected by Ebola 
outbreaks); STOP TB PARTNERSHIP, ADVOCACY, COMMUNICATION AND SOCIAL MOBILIZATION 
SUBGROUP AT COUNTRY LEVEL, ADVOCACY, COMMUNICATION AND SOCIAL MOBILIZATION TO 
STOP TB, WHO Doc. WHO/HTM/STB/2006.37 (2006), http://www.stoptb.org/assets/docu-
ments/resources/publications/acsm/tb-advocacy.pdf (laying out a ten-year strategic frame-
work for advocacy, communication, and social mobilization to combat the spread of tubercu-
losis); Maxine A Whittaker et al., Advocating for Malaria Elimination - Learning from the 
Successes of Other Infectious Disease Elimination Programmes, 13 MALARIA J. (June 5, 
2014), http://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-13-221 (review-
ing the lessons of “globally-coordinated elimination advocacy campaigns” for infectious dis-
eases and how they can be applied towards the elimination of malaria). 
 52.  About Us, MEDECINS SANS FRONTIERES ACCESS CAMPAIGN, http://www.msfac-
cess.org/the-access-campaign (last visited Mar. 15, 2016). 
 53.  See, e.g., WHO, WHO MEDICINES STRATEGY: FRAMEWORK FOR ACTION IN ESSENTIAL 
DRUGS AND MEDICINES POLICY 2000-2003, WHO Doc. WHO/EDM/2000.1 (2000), 
http://apps.who.int/medicinedocs/pdf/whozip16e/whozip16e.pdf. 
 54.  See generally Thomas W. Pogge, Eradicating Systemic Poverty: Brief for a Global 
Resources Dividend, 2 J. HUM. DEV. 59 (2001); Thomas W. Pogge, Human Rights and Global 
Health: A Research Program, 36 METAPHILOSOPHY 182 (2005) [hereinafter Pogge, Human 
Rights and Global Health]. 
 55.  See generally Millennium Promise: About Us, MILLENNIUM VILLAGES PROJECT, 
http://millenniumvillages.org/millenniumpromise (last visited May 5, 2016) (overviewing 
Millennium Promise, an organization co-founded by Jeff Sachs, which “believe[s] that poverty 
in all its forms can be eliminated by 2030, even in the most challenging and remote places in 
the world”). 
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Gates56 have launched a comprehensive movement to combat global 
poverty. The most urgent issue in their campaigns has been the uncon-
scionable mortality rate in less developed nations from the major in-
fectious diseases, notably malaria, tuberculosis, and AIDS.57  Eventu-
ally, the United Nations appointed a Special Rapporteur on Extreme 
Poverty to consolidate these efforts.58 
It can be seen that even as HIV and global poverty movements 
energized the confluence of human rights and essential medicines, the 
movement’s focus remained upstream. That focus did not shift from 
blockages in the sourcing of affordable drugs, like intellectual property 
constraints, to the even more challenging issues that arise along the 
“last kilometer,” between the last links in the supply chains and the 
rights holders’ hands. Rather, and ironically perhaps, even as the HIV 
movement’s demand for universal access to ARV medication went vi-
ral, so to speak, its focus remained upstream, instead of on the ground.    
One final upshot of the upstream focus of the essential medi-
cines/human rights social movement is that the focus on unblocking 
sources of costly drugs through international lawyering and geopoliti-
cal activism has unintentionally entrenched a magical landscape in 
which miracle drugs can zap “real” diseases, while noncommunicable, 
chronic, lifestyle-linked, and especially mental health conditions are 
less worthy of activists’ time. We must redraw that landscape, so that 
all health conditions, from mental illness to malaria to HIV, are treated 
rather than zapped, through networks of care.   
 
 56.  See generally What We Do, BILL & MELINDA GATES FOUND., http://www.gatesfoun-
dation.org/What-We-Do (last visited May 5, 2016) (describing the work of the Bill & Melinda 
Gates Foundation’s Global Development Division: “Nearly 2.5 billion people worldwide live 
on less than US$2 a day, and more than 1 billion suffer from chronic hunger. For these people, 
the basics of food, water, shelter, and sanitation are in short supply, and healthcare and educa-
tion can be unaffordable luxuries. Our Global Development Division aims to identify and fund 
high-impact solutions that can help hundreds of millions of people lift themselves out of pov-
erty and build better lives.”). 
 57.  See Pogge, Human Rights and Global Health, supra note 54, at 182–84; Global Fund 
Overview, GLOBAL FUND, http://www.theglobalfund.org/en/overview/ (last visited Mar. 15, 
2016) (describing the fund as a “partnership organization designed to accelerate the end of 
AIDS, tuberculosis and malaria as epidemics”). See generally Marcella M. Alsan et al., Pov-
erty, Global Health and Infectious Disease: Lessons from Haiti and Rwanda, 25 INFECTIOUS 
DISEASE CLINICS N. AM. 611 (2011) (exploring the association between poverty and communi-
cable disease based on the authors’ experiences in Haiti and Rwanda). 
 58.  See Special Rapporteur on Extreme Poverty and Human Rights, U.N. OFF. HIGH 
COMMISSIONER FOR HUM. RTS. [OHCHR], 
http://www.ohchr.org/EN/Issues/Poverty/Pages/SRExtremePovertyIndex.aspx (last visited 
Mar. 15, 2016). 
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D. Recalling Alma Ata 
Eventually the HIV crisis brought home to essential medi-
cines/human rights activists that it takes more than unblocking drug 
supplies at the international and national levels in order to ensure that 
essential medicines reach the rights holders who need them. When 
health systems and rights holders are under-resourced, sometimes dis-
persed across wide areas, and in need of drug regimes embedded in 
long-term treatment practices—when all of these challenges are there, 
as they almost always are—then it takes more than formal lists, patent 
overrides, inspiring court decisions, and global activists’ fervor to get 
those treatments transmuted into ongoing care.  South Africa was con-
fronted by this multiplex challenge in implementing the spirit as well 
as the letter of their Constitutional Court’s landmark decision in Min-
ister of Health v. TAC in order to get ARVs to all the entitled rights 
holders in need.59 
In this context, a separate history of insight and action about pub-
lic health system design has been recovered and mined. This history 
began at the 1978 International Conference on Primary Health Care 
held in Alma Ata, in what is now Kazakhstan but was then part of the 
former Soviet Union.60 At this path breaking conference, representa-
tives from developing and other nations came together to synthesize 
insights from a plethora of experimental practices in under-resourced 
regions. Their goal was to articulate a plural vision of health care de-
livery systems for multiple under-resourced settings. The common 
theme in this vision would be three grounding elements. The first was 
strong state responsibility for the funding and oversight of each na-
tion’s primary care-based health system. The second was the integra-
tion of all three tiers of the system (i.e., primary, secondary, and ter-
tiary care). The third was the creative design of primary health care 
institutions, networks, and networks of community engagement on the 
ground.61 
The Alma Ata vision thus drew on innovations in primary health 
 
 59.  See Nathaniel Bruhn, Litigating against an Epidemic: HIV/AIDS and the Promise of 
Socioeconomic Rights in South Africa, 17 MICH. J. RACE & L. 181, 201–2, 206–7, 209–10 
(2011); Lisa Forman, Ensuring Reasonable Health: Health Rights, the Judiciary, and South 
African HIV/AIDS Policy, 33 J.L. MED. & ETHICS 711, 720 (2005). 
 60.  Joint Report of the Director-General of the WHO and the Director of the UNICEF, 
Primary Health Care: Report of the International Conference on Primary Health Care (Sept. 
1978) [hereinafter Joint Report]. 
 61.  WHO & U.N. Children’s Fund [UNICEF] International Conference on Primary 
Health Care, Declaration of Alma-Ata art. V–VIII (Sept. 1978), http://www.who.int/publica-
tions/almaata_declaration_en.pdf [hereinafter Declaration of Alma-Ata]. 
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care from China, Latin America, and other areas over prior decades, in 
which patients, families, community members, “barefoot” medical 
workers, trained paraprofessionals, and highly schooled medical pro-
fessionals were drawn into working together to create virtuous circles 
of care.62 The Alma Ata vision was inspired by a politics of both pop-
ulist participation and social movement activism.63 It endorsed an ex-
pansive interpretation of the United Nations’ formal commitment to a 
universal right to health.64 Yet at the same time the conference partici-
pants also endorsed key features of “western” health systems, like its 
conception of professional expertise, its technologies, and its listings 
of essential medicines medications.65 Indeed, the Alma Ata Declara-
tion’s section VII, subpart 3, after listing several political and eco-
nomic essentials of exemplary PHC systems, states that all of these 
systems must “at least” include the universal “provision of essential 
drugs.”66 
The Alma Ata vision for primary health care institutional design 
has been put into practice in several contemporary settings, with re-
markable results. These settings include Partners in Health co-founder 
Paul Farmer’s community-based primary health care clinics in Haiti, 
Rwanda, the urban United States, Ebola-affected Sierra Leone, and 
elsewhere. True to Alma Ata’s call for system integration, all of these 
clinics were nested in the host nations’ public health systems.67 Such 
settings also include South Africa’s “treatment literacy” programs. 
 
 62.  See Fran Baum, Health for All Now! Reviving the Spirit of Alma Ata in the Twenty-
First Century: An Introduction to the Alma Ata Declaration, 2 SOC. MED. 34, 34 (2007); Mar-
cos Cueto, The Origins of Primary Health Care and Selective Primary Health Care, 94 AM. 
J. PUB. HEALTH 1864, 1864–66 (2004). 
 63.  Id. 
 64.  See OHCHR & WHO, THE RIGHT TO HEALTH: FACT SHEET NO. 31 9–10 (2008), 
http://www.ohchr.org/Documents/Publications/Factsheet31.pdf. Compare Declaration of 
Alma-Ata, supra note 61 (reiterating and specifying the Conference’s goals of achieving 
“health for all” or “health care for all” throughout) with G.A. Res. 2200A (XXI), annex, supra 
note 26. 
 65.  See, e.g., Joint Report, supra note 60, ¶¶ 73, 130, 133. See generally NITSAN CHOREV, 
THE WORLD HEALTH ORGANIZATION BETWEEN NORTH AND SOUTH 87–93, 97–98 (2012) (dis-
cussing the history of compromise between the aspirational goals of Alma Ata and Western 
industry prerogatives in the Declaration’s endorsement of “appropriate” technology transfer 
and essential drugs lists). 
 66.  Declaration of Alma-Ata, supra note 61, art. VII(3). 
 67.  See generally Betsy McKay, West Africa Struggles to Rebuild Its Ravaged Health-
Care System, WALL ST. J. (June 4, 2015), http://www.wsj.com/articles/africa-struggles-to-re-
build-its-ravaged-health-care-system-1433457230. Dr. Paul Farmer—a Harvard professor and 
co-founder of the Boston-based charity Partners in Health—has been recently immersed in the 
challenge of combating the Ebola virus in conjunction with the governments of Liberia, Sierra 
Leone, and Guinea, which for years have all been racked by civil wars, coups, and unrest. Id. 
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These were grassroots education, peer support, and empowerment pro-
grams linked with government primary health care centers, mostly in 
rural areas, which distributed ARVs. These treatment literacy sites 
could become catalysts for transforming the primary health centers in 
which they were situated from within.68 These programs were created 
to draw HIV-positive clinic patients into participatory educational pro-
grams to enable them to adhere to complex ARV regimes. Yet the pro-
grams’ protocols were more elaborate, drawing all of the clinics’ stake-
holders, including all patients, HIV-positive or not, providers, and 
community members into linked practices of care. In recent years, the 
WHO, health systems think tanks, university-based public health 
scholars, and others have explicitly recalled Alma Ata in creating 
health systems in challenging settings, such as post-conflict nations 
and stressed urban areas.69 With regard to essential drugs, it is increas-
ingly becoming accepted that it is in Alma Ata’s vision for primary 
health care design, rather than the formal pronouncement, that the right 
to essential medicines, from rights holders’ perspectives at least, is 
likely to come within reach.    
E. An Unrealized Potential 
Alma Ata’s significance to the essential medicines as human 
rights movement is increasingly recognized. Yet the Alma Ata vision 
could have done more. For the essential medicines and human rights 
convergence has failed to challenge either the skewed priorities of the 
essential medicines policy concept or the dysfunctions embedded in 
primary health care institutional design. Instead of either of these two 
potential priorities, the essential medicines and human rights social 
movement has focused on universal access to drugs for infectious dis-
eases, especially in sub-Saharan Africa. As we saw above, the first 
such disease that the movement targeted was AIDS. It then expanded 
its focus to drugs for two other major infectious diseases, malaria and 
tuberculosis. Then, in the context of the global poverty movement, the 
movement has begun to campaign to make treatments for waterborne 
 
 68.  See generally Heywood, supra note 48, at 17–19. 
 69.  See, e.g., Baum, supra note 62, at 40; Max Cooper et al., Post-Conflict Healthcare 
Reconstruction: Yemen and the Window of Opportunity for Primary Care, J. GLOBAL HEALTH 
(Apr. 1, 2015), http://www.ghjournal.org/post-conflict-healthcare-reconstruction-yemen-and-
the-window-of-opportunity-for-primary-care (evoking the Alma Ata Declaration while rec-
ommending Yemen focus on primary care as a post-conflict developing state); Nikolaos 
Oikonomou & Anargiros Mariolis, How Is Greece Conforming to Alma-Ata’s Principles in 
the Middle of Its Biggest Financial Crisis?, 60 BRIT. J. GEN. PRAC. 456, 456–57 (2010) (over-
viewing the problems of Greek’s health system in rural, regional, and urban areas and recom-
mending that it more fully embrace and adhere to the Alma Ata Declaration’s emphasis on 
primary care). 
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infectious diseases available as well.70 
At the same time that activists have thus kept drugs for the killer 
infectious diseases at the center of their attention, a number of factors, 
including widespread unconscious bias, have kept the need for sus-
tained drug treatment for NCDs at the margins. For though it is often 
left unsaid, pernicious and mistaken beliefs that NCDs are linked to 
negative lifestyle choices and moral flaws pervade public conscious-
ness.71 Patients with NCDs are sometimes viewed to have less social 
utility than the “worthy” children, youth, and able-bodied adults often 
falsely believed to be most vulnerable to infectious diseases.72 At the 
same time, treatment for NCDs must often be sustained over time. It is 
sometimes only partially effective and requires great patience to pro-
vide. Over time even the most inexpensive drugs required to treat some 
of these diseases—such as insulin and the supplies needed to adminis-
ter it on a daily basis—can become quite expensive, while the drugs 
for other NCDs such as cancer remain totally out of reach.73   
Because of this combination of an explicit focus by essential med-
icines/human rights activists on infectious diseases and a simultaneous 
marginalization in public consciousness of NCDs, the need for Alma 
Ata-inspired primary care innovations—which would put the features 
of NCD treatment at its center—has been too often overlooked.74 
 
 70.  See Alsan et al., supra note 57; Joia Mukherjee, Cholera in Haiti: Another Disease 
of Poverty in a Traumatized Land, PARTNERS IN HEALTH (Oct. 22, 2010), 
http://www.pih.org/blog/cholera-in-haiti-another-disease-of-poverty-in-a-traumatized-land 
(describing cholera’s connections to poverty and Partner In Health’s efforts to combat cholera 
and waterborne diseases in Haiti). 
 71.  See Jacquineau Az. . .tsop & Tisha R. Joy, Epistemological and Ethical Assessment 
of Obesity Bias in Industrialized Countries, 6 PHIL. ETHICS & HUMAN. MED. (Dec. 16, 2011), 
http://www.peh-med.com/content/6/1/16; Jens Seeberg & Lotte Meinert, Can Epidemics Be 
Noncommunicable?: Reflections on the Spread of ‘Noncommunicable’ Diseases, 2 MED. 
ANTHROPOLOGY THEORY 54, 56–57, 60 (2015). 
 72.  See WHO First Ministerial Conference on Healthy Lifestyles and Noncommunicable 
Disease Control, Conference Proceedings, at 12 (Apr. 2011), 
http://www.who.int/nmh/events/moscow_ncds_2011/conference_documents/conference_re-
port.pdf; Anthony Maher & Devi Sridhar, Political Priority in the Global Fight against Non–
Communicable Diseases, 2 J. GLOBAL HEALTH (Dec. 2012), at 4, 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529321/pdf/jogh-02-020403.pdf. 
 73.  See generally Dele Abegunde, ESSENTIAL MEDICINES FOR NON-COMMUNICABLE 
DISEASES (NCDS), at 11–19, 23, WHO (2011), http://apps.who.int/medicinedocs/docu-
ments/s19716en/s19716en.pdf (overviewing the cost burdens and accessibility issues of es-
sential medicines for diabetes, cancer, and other conditions in the developing world and advo-
cating the development of evidence-based clinical guidelines to promote the appropriate use 
and prescribing of NCD medicines); David J. Hunter & K. Srinath Reddy, Noncommunicable 
Diseases, 369 NEW ENG. J. MED. 1336, 1340–41 (2013). 
 74.  Alessandro R. Demaio et al., Primary Health Care: A Strategic Framework for the 
Prevention and Control of Chronic Non-Communicable Disease, 7 GLOBAL HEALTH ACTION 
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How would Alma Ata-inspired primary health care work for 
NCDs? The answer is straightforward. Such a primary health care set-
ting would provide the multi-dimensional systems of ground-level pa-
tient education, peer support, professional back-up, and care that 
would enhance complex drug treatment while empowering patients, 
family, communities, and providers to work together to share, and en-
hance, everyone else’s care. Without such systems, neither patients nor 
essential others get the medication, treatments, support, or ecosystems 
of caring others that they need for both specifically diagnosed condi-
tions and overall well-being. 
Thus, if the essential medicines/human rights activists want to 
catch up, they will have to bring the margin of NCDs and mental health 
conditions back into the center of essential medicines/human rights 
concerns, as feminist scholar Bell Hooks advised in the context of 
black women’s feminist movement.75 Essential medicine human rights 
advocates will have to join with treatment system scholars and activ-
ists76 to create effective networks of care. To face up to these chal-
lenges, they will have to work through several tensions in human rights 
discourse itself. Some of these tensions draw from trends I have al-
ready identified above. 
The first tension arises when treatment is reduced by human 
rights and essential medicines scholars/activists to the ingestion of a 
thing, one product, or one pill in a market basket of economic and so-
cial goods. Yet, to put it simply, getting pills inside people’s bodies, 
without more, will not necessarily give them the treatment they re-
quire. In fact, simply putting pills into people’s bodies outside the con-
text of systems of care, risks being perceived as unhelpful, intrusive, 
or even violent. 
The second tension arises around the question of scale of the es-
sential medicines problem. The tendency here is to impose a rigid con-
ceptual separation across different “levels” of political space tasked 
with addressing this issue based on different governmental jurisdic-
tions, in the terms set by current international and domestic laws. In 
 
(Aug. 4, 2014), http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122819/pdf/GHA-7-
24504.pdf (recognizing the “paucity of guiding frameworks for legislative measures” to ad-
dress death and disability caused by NCDs and advocating a primary health care approach to 
the problem). 
 75.  See HOOKS, supra note 15. 
 76.  See generally Jim Yong Kim, Paul Farmer, & Michael E. Porter, Redefining Global 
Health-Care Delivery, 382 LANCET 1060 (2013) (discussing the emerging global movement 
for health rights realization, including the right to treatment with essential medicines and the 
right for holistic systems of care, from rights holders’ perspectives). 
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this mapping, the first level is the “micro” or local governmental juris-
diction. The second level is the “mid-level” or national, and the third 
level is the “macro” or international and transnational. The challenge 
here is to keep all three of these legal/social/cultural domains in view 
and acknowledging their jurisdictions, while at the same time engaging 
with the potential synergies among them. This involves ongoing mo-
tion and interaction from one to another at the same time. Thus, the 
vision to the solution must be ecological rather than categorical. With-
out such a way of seeing it, is all too easy to imagine “solutions” to a 
multi-dimensional challenge in terms of dichotomies. For example, it 
becomes too tempting to understand the “right” to essential medicines 
as a question of inadequate international intellectual property regimes, 
dysfunctional national delivery systems, corrupt local officials, or 
greedy pharmaceutical conglomerates, rather than all of the above sys-
tems, minus the anthropomorphic adjectives, interacting with one an-
other. 
Transcending the micro/mid-level/macro trichotomy is enabled 
by embedding the implementation of the essential medicines right into 
primary care systems that are in turn nested in wider ecologies of care, 
rather than either producing more drugs full stop, or improving inter-
national law. An image of ecologies of care in turn suggests new points 
where scholars and advocates can enter into the essential medi-
cines/health rights domain. Asking for more and cheaper drugs from 
big pharmaceutical companies may feel cathartic. The demand might 
fuel social anger. But it will not help untangle the intricate webs of law 
that configure both big pharmaceuticals’ power and the dynamics 
through which that power in turn disempowers the lowest income peo-
ple who need health care. 
Such webs of law do not just include the WHO’s 2015 essential 
medicines list. And they do not just include international intellectual 
property law and the WTO. The webs also include bilateral investment 
treaties, international tax treaties, global financial arrangements, local 
organizing activities, and laws that govern antitrust and incorporation 
that might be used either to facilitate—or to obstruct—the formation 
of huge health care conglomerates in low income communities as well 
as wealthy nations. 
Further attention must also be paid to the webs of laws, both na-
tional and international, that could be put in place to enable the emer-
gence of health systems more adequate to offer good care in low in-
come nations. Such laws might include frameworks to incentivize the 
WHITEFINALBOOKPROOF (DO NOT DELETE) 2/16/2017  2:48 PM 
2016] GETTING REAL ABOUT ESSENTIAL MEDICINES 103 
adaptation of diagnostic and treatment modalities designed for rich na-
tions’ but adaptable for use in less-resourced settings. A final domain 
that warrants creative attention is the loss of medical workers —both 
professional and lay—from health sites already depleted of material 
resources. This drain is taking place across rich and poor regions of 
developed nations as well as across north/south borders in the global 
south.77 How can cross-regional and cross-national partnerships target 
funding and configure workable laws to address these inequitable ge-
ographies in a world where income inequality is everywhere? Once the 
micro/mid-level/macro blinders are loosened and the map becomes 
more nuanced, one opportunity suggests another. It will take collabo-
rative work to fill in all of the domains. 
IV. BACK TO THE CHALLENGE OF MENTAL HEALTH CARE 
A capacious vision of health rights/essential medicines is needed 
in every domain including the epicenter of the essential medicines fo-
cus so far, that is the fight against infectious disease. Yet, that said, the 
need is starkly apparent in the case of mental health care. Indeed, the 
mental health challenge is a “canary in the coal mine” with respect to 
the urgent need for a different kind of essential medicines/human rights 
activism in every health domain. For the mental health challenge, both 
in the United States and in developing nations, exposes the fact that 
maintaining all people’s highest level of well-being is a “chronic” en-
deavor. For every disease, and every person, this task is an ongoing 
practice of care. 
Here are just a few features of that challenge. The first is obtain-
ing adequate funding. That should go without saying. For you cannot 
calm A’s agitation on an ongoing basis without the drugs, staff, tech-
nologies, and equipment that can help. Indeed, in part because of ac-
tivist effort, the health financing systems in many developing nations 
were pushed beyond a scheme that required even people with little or 
no cash income nonetheless to pay cash before treatment even for ur-
gent health needs. Today, in Ghana for instance, health care is financed 
by a generous national health insurance scheme.78 The scheme includes 
the right to a long list of medications for those who can afford to pay 
 
 77.  See Gamal I. Serour, Healthcare Workers and the Brain Drain, 106 INT’L J. 
GYNECOLOGY & OBSTETRICS 175 (2009). 
 78.  See National Health Insurance Act (Act No. 852/2012) (Ghana); About Us: Brief In-
troduction to the NHIS, NAT’L HEALTH INS. SCHEME, http://www.nhis.gov.gh/about.aspx (last 
visited Mar. 15, 2016). 
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premiums and registration fees.79 Yet if they cannot pay, then the na-
tional Mental Health Act and National Health Insurance Act provide 
that mental health patients are entitled to receive free needed medica-
tions as well as free care.80 
The current Mental Health Act81 was revised from the prior colo-
nial version only in 2012. It authorizes the creation of a special tax-
financed fund earmarked for mental health expenditures for multiple 
types of care.82 Yet even if this fund becomes large, most of its pro-
ceeds are likely to be targeted to national level tertiary services in ex-
isting psychiatric hospitals, the training of high-level professionals, 
and the like. The fund is not nearly as likely to fund Alma Ata-inspired 
networks of ground-level services embedded in wider fabrics of care. 
It is the lack of such networks that could make a great difference 
in the case of A and the many others who, like her, are challenged by 
mental—and somatic— health conditions. Let us take her situation as 
the example and assume that the lithium and backup medications she 
needs are already available in primary care settings in all geographic 
regions. She still needs at least three more conditions in place to ensure 
her right to high quality care. First, she needs access to the equipment 
and capacity to have those drugs administered where she actually is on 
an ongoing basis, on the ground. Thus, in the case of lithium and many 
other drugs, she needs the clinic, and her home, to have access to clean 
needles, clean water, skin disinfectants, and trained people to draw the 
blood and read the results. If all of these capacities cannot be accom-
modated, then alternative testing methods must be adapted to work in 
less-resourced settings. 
Second, she needs supplemental treatments tailored to the chal-
lenges she faces along with the agitation, like therapies for the over-
whelming sensory input, social stress, and sleep deprivation, which can 
spiral into further agitation. These treatments, as well as basic mental 
health education, are critical for guarding against both stigma, and the 
self-stigma, that can lead to self-doubt, despair, and exploitation. They 
must be available for her, her family, and her neighbors through local 
health advocates and community volunteers. For without such prac-
tices (although they can arguably be called “medicines”), all the drugs 
that money can buy are unlikely to cure or even manage either mental 
 
 79.  See supra note 10. 
 80.  See supra note 9. 
 81.  Mental Health Act of 2012 (Act No. 846/2012). 
 82.  Id. §§ 80–85. 
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health conditions or indeed any other health challenge. 
Third, A and all others with health conditions need people to be 
there in whatever ways that are feasible under the circumstances. 
These must include highly trained mental health professionals who de-
sign, manage, monitor, and realize whole systems of care and provide 
its most technologically “high-level” care. I might underscore here that 
though Ghana, for instance, has too few of these people in numbers, its 
mental health leadership team has worldwide renown.83 But such 
highly trained people are not the only caring people that health-chal-
lenged people need around them to thrive. They also need people at the 
primary care and mobile outreach levels, community and family vol-
unteers, peer supporters, spiritual counselors, paralegal advocates, and 
more. All of these must be trained to work together and drawn together 
into caring teams. These networks of care must be complemented by 
networks in civil society, all working together on public education; 
peer and family activism; policy advocacy; and anti-stigma campaigns. 
Without this dimension of the work, the political will to maintain ro-
bust legal frameworks for health funding, patient crisis management, 
and front line care will erode. Fearful, exploitive responses to health 
challenges, be they cancer, epilepsy, polio, or mental health conditions, 
for instance, will continue, and the work of health providers and family 
members themselves, as they try to cope, can become a target of human 
rights chastisement and shaming on a global stage.   
These objectives echo the Alma Ata Declaration and the earlier 
practices it drew from.  Furthermore, these objectives are belatedly be-
ing “found” to be “evidence-based” and thus drawn upon in primary 
health care design in rich but unequal nations like the United States. 
Furthermore, such practices are proving effective in managing other 
NCDs and even infectious diseases, among all socioeconomic groups 
in all regions of the globe.84   
It is incumbent on the essential medicines/health rights movement 
to keep up with these developments. Chemicals must be re-conceptu-
alized as just one part of the networks of care that are required and 
must therefore be designed, resourced, and put in place, in order to 
deliver the treatments consistent with all people’s highest attainable 
 
 83.  For instance, the Chief Psychiatrist of the Ghana Health Service, Dr. Akwasi Osei, 
has long been a faculty member at the WHO-sponsored global university program on mental 
health and human rights located each year in Pune, India.  See Indian Law Society & WHO, 
International Diploma in Mental Health Law and Human Rights 2011–2012, at 4, 25, 
http://enil.eu/wp-content/uploads/2011/06/Prospectus-2011-12.pdf. 
 84.  See Rebecca Onie, Paul Farmer, & Heidi Behforouz, Realigning Health with Care, 
STAN. SOC. INNOVATION REV., Summer 2012, at 28. 
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level of mental and physical health. We need to move beyond an ob-
session with intellectual property reform as the only key to essential 
medicine rights and toward understanding that decreasing the cost of 
expensive drugs is but a single part of what it will take to deliver the 
essentials of rights-based care. For within the “coal mine” of mental 
health care, unpatented, inexpensive, and widely available medication 
is both already there and not yet fully accessed, and that is a compre-
hensive circle. To realize the human rights to essential medicines, we 
need to draw our work toward it and bring it into reach. 
